Literature DB >> 1316433

Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere.

D Fults1, C A Pedone, H G Morse, J W Rose, R D McKay.   

Abstract

The primitive neuroectodermal tumors (PNET) comprise a class of malignant nervous system neoplasms that afflict children. These tumors consist of cells that are morphologically identical to the primitive neuroepithelial cells normally seen in early stages of neural embryogenesis, supporting the notion that PNET result from a disturbance in the process of normal neuronal or glial differentiation. In the central nervous system, PNET occur most commonly in the cerebellum (medulloblastomas), but only occasionally in the cerebral hemispheres. We report here the establishment and characterization of a new human cell line (PFSK) derived from a PNET from the cerebral hemisphere of a child. The growth characteristics of PFSK cells were typical of an immortalized, transformed cell line. Cytogenetic and molecular genetic studies showed that three different sublines were present. In one of these sublines, sequences from chromosome 17 had been lost during establishment in culture. Immunocytochemical studies showed that PFSK cells expressed nestin, an intermediate filament protein normally expressed by neuroepithelial stem cells during neurulation. The PFSK cells did not express antigens typically found in terminally differentiated neurons or glia, indicating that this tumor cell line might represent neuroepithelial stem cells prior to commitment to a neuronal or glial lineage.

Entities:  

Mesh:

Year:  1992        PMID: 1316433     DOI: 10.1097/00005072-199205000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Pleomorphic primitive neuroectodermal tumor with glial and neuronal differentiation: clinical, pathological, cultural, and chromosomal analysis of a case.

Authors:  Yuji Uematsu; Rie Takehara; Mina Shimizu; Yoshiyuki Tanaka; Toru Itakura; Norihiko Komai
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

Review 2.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

3.  Generation of neural stem cells from discarded human fetal cortical tissue.

Authors:  Jie Lu; Laurent C Delli-Bovi; Jonathan Hecht; Rebecca Folkerth; Volney L Sheen
Journal:  J Vis Exp       Date:  2011-05-25       Impact factor: 1.355

4.  A novel ATXN1-DUX4 fusion expands the spectrum of 'CIC-rearranged sarcoma' of the CNS to include non-CIC alterations.

Authors:  Drew Pratt; Chandan Kumar-Sinha; Marcin Cieślik; Rohit Mehra; Hong Xiao; Lina Shao; Andrea Franson; Evan Cantor; Arul M Chinnaiyan; Rajen Mody; Zied Abdullaev; Kenneth Aldape; Martha Quezado; Sandra Camelo-Piragua
Journal:  Acta Neuropathol       Date:  2021-02-07       Impact factor: 17.088

5.  A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes.

Authors:  Tara Spence; Christian Perotti; Patrick Sin-Chan; Daniel Picard; Wei Wu; Anjali Singh; Colleen Anderson; Michael D Blough; J Gregory Cairncross; Lucie Lafay-Cousin; Douglas Strother; Cynthia Hawkins; Aru Narendran; Annie Huang; Jennifer A Chan
Journal:  Neuro Oncol       Date:  2013-12-04       Impact factor: 12.300

6.  A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas.

Authors:  C De Bustos; A Smits; B Strömberg; V P Collins; M Nistér; G Afink
Journal:  J Med Genet       Date:  2005-01       Impact factor: 6.318

7.  Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell lines.

Authors:  T Tlhyama; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

8.  Oxygen regulates invasiveness and virulence of group B streptococcus.

Authors:  Atul K Johri; Joahnna Padilla; Gennady Malin; Lawrence C Paoletti
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Novel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.

Authors:  Anna Wojtalla; Fabiana Salm; Ditte G Christiansen; Tiziana Cremona; Paulina Cwiek; Tarek Shalaby; Nicole Gross; Michael A Grotzer; Alexandre Arcaro
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

10.  Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.

Authors:  Scott M Belcher; Caleb C Burton; Clifford J Cookman; Michelle Kirby; Gabriel L Miranda; Fatima O Saeed; Kathleen E Wray
Journal:  BMC Pharmacol Toxicol       Date:  2017-09-06       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.